talipexole has been researched along with Cataleptic Attacks in 3 studies
talipexole: dopamine receptor agonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Narcolepsy is a genetically determined disorder of sleep characterized by excessive daytime sleepiness and abnormal manifestations of REM sleep that affects both humans and animals." | 1.29 | Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems. ( Arrigoni, J; Ciaranello, RD; Dement, WC; Edgar, DM; Mignot, E; Nishino, S; Reid, MS; Sharp, LH; Siegel, JM, 1993) |
| "These findings show that cataplexy may be regulated by D2/D3 dopaminergic receptors in the ventral tegmental area and perhaps the globus pallidus/ putamen." | 1.29 | Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. ( Mignot, E; Nishino, S; Reid, MS; Sampathkumaran, R; Siegel, JM; Tafti, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mignot, E | 3 |
| Nishino, S | 3 |
| Sharp, LH | 1 |
| Arrigoni, J | 1 |
| Siegel, JM | 2 |
| Reid, MS | 2 |
| Edgar, DM | 1 |
| Ciaranello, RD | 1 |
| Dement, WC | 1 |
| Tafti, M | 1 |
| Sampathkumaran, R | 1 |
| Honda, K | 1 |
| Riehl, J | 1 |
3 other studies available for talipexole and Cataleptic Attacks
| Article | Year |
|---|---|
Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
Topics: Aging; Animals; Azepines; Biogenic Amines; Brain; Cataplexy; Chromosome Mapping; Crosses, Genetic; D | 1993 |
Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.
Topics: Amygdala; Animals; Azepines; Cataplexy; Disease Models, Animal; Dogs; Dopamine; Dopamine Agents; Dop | 1996 |
Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].
Topics: Animals; Arousal; Azepines; Cataplexy; Dogs; Dopamine Agonists; Electroencephalography; Electromyogr | 1999 |